LifeLogic Pharmaceuticals Owner Pleads Guilty in Misbranded Drugs Case

A Cranston, Rhode Island businessman, Arif Diwan, has pleaded guilty to charges that he and his company, Lifescreen LLC sold pharmaceuticals purchased from India and other countries as FDA-approved medication. Diwan purchased the drugs abroad, then repackaged and forged labels for them in Rhode Island. He sold the drugs with as having been produced by…

[...]

PSM India Initiative Brings Together Government, Industry and Health Care Stakeholders to Help Stop the Spread of Spurious Medicines

PSM India Initiative Brings Together Government, Industry and Health Care Stakeholders to Help Stop the Spread ofSpurious Medicines Organisation Hosts Second National Training Workshop on “Secured Medicines & Robust Pharmacovigilance MUMBAI (26 August 2013) – The Partnership for Safe Medicines (PSM) India Initiative, a public health organisation dedicated to protecting consumers from spurious and not-of-standard…

[...]

Nigeria-bound HIV/AIDS Drugs Seized in Netherlands

Nigeria-bound HIV/AIDS Drugs Seized in Netherlands View larger map What: On November 12, 2008, Dutch authorities seized a shipment of Indian-made abacavir—an antiretroviral drug for HIV/AIDS treatment—bound for Nigeria. The abacavir tablets were found to violate patent rules and were declared counterfeit; however it’s been disputed whether the drugs were actually counterfeit. The Financial Times reported that “dozens” of HIV patients were…

[...]

Defining the Problem

Bryan A.  Liang, MD, PhD, JD

Often understanding a problem begins with a definition.  The World Health Assembly, the decision-making body of the World Health Organization (WHO), meets each May to discuss public health issues and determine future WHO policies.  This year, WHO's constituted International Medical Products Anti-Counterfeiting Taskforce (IMPACT) introduced a resolution to update WHO's definition of a counterfeit medicine.  IMPACT proposed changing the definition from "deliberately and fraudulently" mislabeling a medicine's identity and source to the "false representation" of a medical product's identity, history or source.

[...]

Fake drugs worth Rs 5.3 cr seized

HYDERABAD: The Drugs Control Administration (DCA) has seized Rs 5.36 crore worth of spurious, sub-standard and illegal drugs from godowns and industrial units in the state in the last few weeks. Ironically, Rs 4.80 crore worth of drugs were manufactured without a valid licence. “A special drive was taken up by the DCA from February…

[...]